Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia
Jean‐Arthur Micoulaud‐Franchi, Mélanie Faugère, Laurent Boyer, et al.
Schizophrenia Research (2015) Vol. 165, Iss. 1, pp. 94-96
Closed Access | Times Cited: 25

Showing 25 citing articles:

Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review
Błażej Misiak, Bartłomiej Stańczykiewicz, Kamila Kotowicz, et al.
Schizophrenia Research (2017) Vol. 192, pp. 16-29
Closed Access | Times Cited: 182
Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis
Emre Bora
Psychological Medicine (2019) Vol. 49, Iss. 12, pp. 1971-1979
Closed Access | Times Cited: 117
Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
Laura Orsolini, Fabiola Sarchione, Federica Vellante, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 5, pp. 583-606
Open Access | Times Cited: 88
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
E. Bulzacka, Laurent Boyer, Franck Schürhoff, et al.
Schizophrenia Bulletin (2016) Vol. 42, Iss. 5, pp. 1290-1302
Open Access | Times Cited: 86
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Guillaume Fond, Christophe Lançon, Pascal Auquier, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 76
A significant causal association between C-reactive protein levels and schizophrenia
Masatoshi Inoshita, Shusuke Numata, Atsushi Tajima, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 44
Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder
Evrim Özkorumak Karagüzel, Filiz Civil Arslan, Emel Uysal, et al.
Comprehensive Psychiatry (2018) Vol. 89, pp. 61-66
Open Access | Times Cited: 44
The relationship between salivary C-reactive protein and cognitive function in children aged 11–14 years: Does psychopathology have a moderating effect?
Alexis E. Cullen, Ben M Tappin, Patricia A. Zunszain, et al.
Brain Behavior and Immunity (2017) Vol. 66, pp. 221-229
Open Access | Times Cited: 37
Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
Irfan Ullah, Hashir Ali Awan, Alifiya Aamir, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13032-13032
Open Access | Times Cited: 24
High C-reactive protein levels are associated with depressive symptoms in schizophrenia
Mélanie Faugère, Jean‐Arthur Micoulaud‐Franchi, Catherine Faget-Agius, et al.
Journal of Affective Disorders (2017) Vol. 225, pp. 671-675
Closed Access | Times Cited: 32
Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis
Zhichao Wang, Ping Li, Dianyuan Chi, et al.
Oncotarget (2017) Vol. 8, Iss. 43, pp. 75445-75454
Open Access | Times Cited: 29
Associations between sleep quality and inflammatory markers in patients with schizophrenia
Shih‐Hua Fang, Katsuhiko Suzuki, Chin Leong Lim, et al.
Psychiatry Research (2016) Vol. 246, pp. 154-160
Closed Access | Times Cited: 27
Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
Farivar Fathian, Else‐Marie Løberg, Rolf Gjestad, et al.
Acta Neuropsychiatrica (2018) Vol. 31, Iss. 1, pp. 36-45
Open Access | Times Cited: 21
Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia
Leticia García-Álvarez, María Paz García‐Portilla, Leticia González-Blanco, et al.
Revista de Psiquiatría y Salud Mental (2016) Vol. 9, Iss. 4, pp. 219-227
Closed Access | Times Cited: 19
Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia
Luyao Xia, Dongmei Wang, Jiesi Wang, et al.
Clinical Neurophysiology (2020) Vol. 131, Iss. 3, pp. 725-733
Closed Access | Times Cited: 18
Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia
Na Zhao, Xiaohong Wang, Chuan Yi Kang, et al.
Annals of General Psychiatry (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 16
C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders
Laura Orsolini, Simone Pompili, Umberto Volpe
Advances in experimental medicine and biology (2023), pp. 135-160
Closed Access | Times Cited: 6
Differential blood-based biomarkers of psychopathological dimensions of schizophrenia
Leticia García-Álvarez, María Paz García‐Portilla, Leticia González-Blanco, et al.
Revista de Psiquiatría y Salud Mental (English Edition) (2016) Vol. 9, Iss. 4, pp. 219-227
Closed Access | Times Cited: 15
P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery
Luyao Xia, Lian Yuan, Xiangdong Du, et al.
Schizophrenia Research (2019) Vol. 215, pp. 105-112
Closed Access | Times Cited: 15
Executive functioning trajectories and their prospective association with inflammatory biomarkers in schizophrenia and non-psychiatric comparison participants
David H. Adamowicz, Tsung‐Chin Wu, Rebecca Daly, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 128, pp. 110866-110866
Closed Access | Times Cited: 4
Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?
Maju Mathew Koola, Jeffrey K. Raines, Robert G. Hamilton, et al.
PubMed (2016) Vol. 15, Iss. 5, pp. 52-57
Closed Access | Times Cited: 10
A systematic review and meta‐analysis of abnormalities in hematological and biochemical markers among Bangladeshi COVID‐19 cases
Khokon Kanti Bhowmik, Md Abdul Barek, Md. Abdul Aziz, et al.
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 7
<p>C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia</p>
Chun-Hung Chang, Hsien‐Yuan Lane, Chieh‐Yu Liu, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 2621-2627
Open Access | Times Cited: 8
The interaction between positive schizotypy and high sensitivity C-reactive protein on response inhibition in female individuals
Jingbo Gong, Ya Wang, Jianbo Liu, et al.
Psychiatry Research (2019) Vol. 274, pp. 365-371
Closed Access | Times Cited: 5
A Comparison of the Relationship Between C-Reactive Protein Levels and Cognitive Functions in Patients with Schizophrenia, First-Episode Psychosis, and Healthy Controls
Nefise Demir, Osman A. Yildirim
Psychiatry and Clinical Psychopharmacology (2023) Vol. 32, Iss. 4, pp. 274-284
Open Access
Page 1

Scroll to top